204 related articles for article (PubMed ID: 16698763)
1. A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.
Federico A; Trappoliere M; Tuccillo C; de Sio I; Di Leva A; Del Vecchio Blanco C; Loguercio C
Gut; 2006 Jun; 55(6):901-2. PubMed ID: 16698763
[No Abstract] [Full Text] [Related]
2. [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Trappoliere M; Federico A; Tuccillo C; de Sio I; Di Leva A; Niosi M; D'Auria M; Loguercio C;
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):193-9. PubMed ID: 15990709
[TBL] [Abstract][Full Text] [Related]
3. The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.
Loguercio C; Federico A; Trappoliere M; Tuccillo C; de Sio I; Di Leva A; Niosi M; D'Auria MV; Capasso R; Del Vecchio Blanco C;
Dig Dis Sci; 2007 Sep; 52(9):2387-95. PubMed ID: 17410454
[TBL] [Abstract][Full Text] [Related]
4. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
Loguercio C; Andreone P; Brisc C; Brisc MC; Bugianesi E; Chiaramonte M; Cursaro C; Danila M; de Sio I; Floreani A; Freni MA; Grieco A; Groppo M; Lazzari R; Lobello S; Lorefice E; Margotti M; Miele L; Milani S; Okolicsanyi L; Palasciano G; Portincasa P; Saltarelli P; Smedile A; Somalvico F; Spadaro A; Sporea I; Sorrentino P; Vecchione R; Tuccillo C; Del Vecchio Blanco C; Federico A
Free Radic Biol Med; 2012 May; 52(9):1658-65. PubMed ID: 22343419
[TBL] [Abstract][Full Text] [Related]
5. Effect of silybin on high-fat-induced fatty liver in rats.
Yao J; Zhi M; Minhu C
Braz J Med Biol Res; 2011 Jul; 44(7):652-9. PubMed ID: 21755261
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose.
Sciacqua A; Perticone M; Tripepi G; Addesi D; Cassano V; Maio R; Sesti G; Perticone F
Intern Emerg Med; 2019 Jan; 14(1):77-84. PubMed ID: 30232738
[TBL] [Abstract][Full Text] [Related]
7. [Silymarin in the treatment of chronic liver diseases: past and future].
Fehér J; Lengyel G
Orv Hetil; 2008 Dec; 149(51):2413-8. PubMed ID: 19073452
[TBL] [Abstract][Full Text] [Related]
8. A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes.
Grattagliano I; Diogo CV; Mastrodonato M; de Bari O; Persichella M; Wang DQ; Liquori A; Ferri D; Carratù MR; Oliveira PJ; Portincasa P
World J Gastroenterol; 2013 May; 19(20):3007-17. PubMed ID: 23716980
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
Federico A; Dallio M; Masarone M; Gravina AG; Di Sarno R; Tuccillo C; Cossiga V; Lama S; Stiuso P; Morisco F; Persico M; Loguercio C
Oxid Med Cell Longev; 2019; 2019():8742075. PubMed ID: 31737175
[TBL] [Abstract][Full Text] [Related]
10. Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
Lirussi F; Beccarello A; Zanette G; De Monte A; Donadon V; Velussi M; Crepaldi G
Diabetes Nutr Metab; 2002 Aug; 15(4):222-31. PubMed ID: 12416659
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of silybin-phospholipid complex intervention on amiodarone-induced fatty liver in mice].
Sun SS; Wu YX; Cheng ML; Chen CW; Peng YS; Miao Q; Bian ZL; Wang XJ; Fu QC
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):45-50. PubMed ID: 30685923
[No Abstract] [Full Text] [Related]
12. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
13. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Abenavoli L; Greco M; Nazionale I; Peta V; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):519-27. PubMed ID: 25617046
[TBL] [Abstract][Full Text] [Related]
14. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver Disease.
Poulos JE; Kalogerinis PT; Milanov V; Kalogerinis CT; Poulos EJ
J Diet Suppl; 2022; 19(3):287-302. PubMed ID: 33491528
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.
Di Sario A; Bendia E; Taffetani S; Omenetti A; Candelaresi C; Marzioni M; De Minicis S; Benedetti A
Dig Liver Dis; 2005 Nov; 37(11):869-76. PubMed ID: 16169303
[TBL] [Abstract][Full Text] [Related]
17. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.
Patrick L
Altern Med Rev; 2002 Aug; 7(4):276-91. PubMed ID: 12197781
[TBL] [Abstract][Full Text] [Related]
19. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice.
Guo Y; Wang S; Wang Y; Zhu T
Pharm Biol; 2016 Dec; 54(12):2995-3000. PubMed ID: 27387273
[TBL] [Abstract][Full Text] [Related]
20. The treatment of NAFLD.
Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
